Answers are grounded in this paper and cite their sources.
As part of the innate immune system, natural killer (NK) cells form the first line of defence against pathogens or transformed/cancerous host cells. Recent experimental and clinical data show the possibility of exploiting NK activity as a cell-based immunotherapy to treat cancer. This review discusses the recent knowledge on NK cell biology that has impacted on its development as a treatment for cancer.
No takes yet. Share an insight, caveat, or question.
Arai et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: